Reproductive endocrinology

Gender-affirming hormone therapy and its impact on myocardial mass and cardiac function: a prospective magnetic resonance cohort study on transgender men and women

Eur J EndocrinolPublished Prospective cohort study

Authors' conclusion

Myocardial mass increased, while NT-proBNP levels decreased significantly in AFAB after 6 months of GAHT. However, no significant changes in cardiac function were noted in AMAB and AFAB.

Study context

Population
Transgender individuals under gender-affirming hormone therapy (GAHT), Medical University of Vienna, 2019–2022
Participants
20 vs 15
Exposure
Before vs after 6 months of GAHT in AFAB and AMAB transgender individuals
  • AFABn = 20
  • AMABn = 15
Outcome
Myocardial mass
Follow-up
6 months
Methodological detailssingle-centre, cardiac MRI, magnetic resonance spectroscopy
  • Single-centre
  • Cardiac MRI
  • Magnetic resonance spectroscopy

Main finding

As reported in the abstract

AFAB: myocardial mass increased significantly from mean (±SD) 48 (±8) g/m² at baseline to 54 (±7) g/m²
P = .011
AMAB: nonsignificant decrease in myocardial mass
4 (±14) g/m²

Observational data: associations, not effects.

Further findings

Left ventricular ejection fraction (LVEF), stroke volume, cardiac output, peak filling rate · 6 months

No significant changes in either group

Correlation of sex hormones and BMI with myocardial mass at follow-up

Testosterone, AFAB
r = −0.127, P = .679
Testosterone, AMAB
r = −0.127, P = .679
Estradiol, AFAB
r = −0.154, P = .616
Estradiol, AMAB
r = −0.154, P = .616
BMI not related to myocardial mass

Brain natriuretic peptide levels in AFAB · 6 months

Significantly reduced from median [IQR] 41 [26-57] to 19 [12-34] pg/mL

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Gender-affirming hormone therapy and its impact on myocardial mass and cardiac function: a prospective magnetic resonance cohort study on transgender men and women. Eur J Endocrinol. Published 28 March 2025. doi:10.1093/ejendo/lvaf057

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.